oral glp 1 inhibitor Eli Lilly's GLP-1 Therapy Foundayo (orforglipron) Is Now Available for Weight Loss Oral GLP-1 Weight Loss Medication

Both medications are available in Australia, with Ozempic PBS-subsidised for diabetes and Wegovy privately available

however, in other infusion studies with the GLP-1 receptor agonist exenatide, measured GFR (mGFR) was increased in healthy volunteers (26) and unchanged in people with T2D (30)

I am happier

Gastrointestinal adverse events associated with GLP-1 RA in non-diabetic patients with overweight or obesity: A systematic review and network meta-analysis

Telehealth for Branded Medications Starts at $39 for an initial 30-day trial (medication not included)

Implications for GLP-1 drugmakers and pharmacies: The two dominant weight loss drug makers, Novo Nordisk and Eli Lilly, have mostly figured out how to meet escalating consumer demand for GLP-1s